+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Vaccines Market 2025-2029

  • PDF Icon

    Report

  • 194 Pages
  • January 2025
  • Region: Global
  • TechNavio
  • ID: 4855486
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vaccines market is forecasted to grow by USD 193.7 billion during 2024-2029, accelerating at a CAGR of 23% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.

The vaccines market is segmented as below:

By Type

  • Human vaccine
  • Animal vaccine

By End-user

  • Hospitals
  • Clinics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccines market growth during the next few years. Also, increase in awareness of vaccine-preventable diseases among travelers and advancement in vaccine delivery system will lead to sizable demand in the market.

The report on the vaccines market covers the following areas:

  • Vaccines Market sizing
  • Vaccines Market forecast
  • Vaccines Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co., Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GSK Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Vaccines Market 2019 - 2023
Historic Market Size - Data Table on Global Vaccines Market 2019 - 2023 ($ billion)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on the Global Vaccines Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Human vaccine - Market size and forecast 2024-2029
Chart on Human vaccine - Market size and forecast 2024-2029 ($ billion)
Data Table on Human vaccine - Market size and forecast 2024-2029 ($ billion)
Chart on Human vaccine - Year-over-year growth 2024-2029 (%)
Data Table on Human vaccine - Year-over-year growth 2024-2029 (%)
8.4 Animal vaccine - Market size and forecast 2024-2029
Chart on Animal vaccine - Market size and forecast 2024-2029 ($ billion)
Data Table on Animal vaccine - Market size and forecast 2024-2029 ($ billion)
Chart on Animal vaccine - Year-over-year growth 2024-2029 (%)
Data Table on Animal vaccine - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Type
Market opportunity by Type ($ billion)
Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ billion)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
9.4 Clinics - Market size and forecast 2024-2029
Chart on Clinics - Market size and forecast 2024-2029 ($ billion)
Data Table on Clinics - Market size and forecast 2024-2029 ($ billion)
Chart on Clinics - Year-over-year growth 2024-2029 (%)
Data Table on Clinics - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.11 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.12 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.16 Russia - Market size and forecast 2024-2029
Chart on Russia - Market size and forecast 2024-2029 ($ billion)
Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
Chart on Russia - Year-over-year growth 2024-2029 (%)
Data Table on Russia - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product/Service
Astellas Pharma Inc. - Key offerings
SWOT
14.5 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product/Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
14.6 Bavarian Nordic AS
Bavarian Nordic AS - Overview
Bavarian Nordic AS - Product/Service
Bavarian Nordic AS - Key offerings
SWOT
14.7 Bharat Biotech Ltd.
Bharat Biotech Ltd. - Overview
Bharat Biotech Ltd. - Product/Service
Bharat Biotech Ltd. - Key offerings
SWOT
14.8 BrightPath Biotherapeutics Co., Ltd.
BrightPath Biotherapeutics Co., Ltd. - Overview
BrightPath Biotherapeutics Co., Ltd. - Product/Service
BrightPath Biotherapeutics Co., Ltd. - Key offerings
SWOT
14.9 CSL Ltd.
CSL Ltd. - Overview
CSL Ltd. - Business segments
CSL Ltd. - Key news
CSL Ltd. - Key offerings
CSL Ltd. - Segment focus
SWOT
14.10 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product/Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
SWOT
14.11 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product/Service
Emergent BioSolutions Inc. - Key offerings
SWOT
14.12 GSK Plc
GSK Plc - Overview
GSK Plc - Business segments
GSK Plc - Key news
GSK Plc - Key offerings
GSK Plc - Segment focus
SWOT
14.13 Gradalis Inc.
Gradalis Inc. - Overview
Gradalis Inc. - Product/Service
Gradalis Inc. - Key offerings
SWOT
14.14 Johnson and Johnson Inc.
Johnson and Johnson Inc. - Overview
Johnson and Johnson Inc. - Business segments
Johnson and Johnson Inc. - Key news
Johnson and Johnson Inc. - Key offerings
Johnson and Johnson Inc. - Segment focus
SWOT
14.15 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
SWOT
14.16 Novavax Inc.
Novavax Inc. - Overview
Novavax Inc. - Product/Service
Novavax Inc. - Key offerings
SWOT
14.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.18 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2024 and 2029
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value chain analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 21: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Historic Market Size - Data Table on Global Vaccines Market 2019 - 2023 ($ billion)
Exhibits 25: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits 26: Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 29: Five forces analysis - Comparison between 2024 and 2029
Exhibits 30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 35: Chart on Market condition - Five forces 2024 and 2029
Exhibits 36: Chart on Type - Market share 2024-2029 (%)
Exhibits 37: Data Table on Type - Market share 2024-2029 (%)
Exhibits 38: Chart on Comparison by Type
Exhibits 39: Data Table on Comparison by Type
Exhibits 40: Chart on Human vaccine - Market size and forecast 2024-2029 ($ billion)
Exhibits 41: Data Table on Human vaccine - Market size and forecast 2024-2029 ($ billion)
Exhibits 42: Chart on Human vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Human vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 44: Chart on Animal vaccine - Market size and forecast 2024-2029 ($ billion)
Exhibits 45: Data Table on Animal vaccine - Market size and forecast 2024-2029 ($ billion)
Exhibits 46: Chart on Animal vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Animal vaccine - Year-over-year growth 2024-2029 (%)
Exhibits 48: Market opportunity by Type ($ billion)
Exhibits 49: Data Table on Market opportunity by Type ($ billion)
Exhibits 50: Chart on End-user - Market share 2024-2029 (%)
Exhibits 51: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 52: Chart on Comparison by End-user
Exhibits 53: Data Table on Comparison by End-user
Exhibits 54: Chart on Hospitals - Market size and forecast 2024-2029 ($ billion)
Exhibits 55: Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion)
Exhibits 56: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Clinics - Market size and forecast 2024-2029 ($ billion)
Exhibits 59: Data Table on Clinics - Market size and forecast 2024-2029 ($ billion)
Exhibits 60: Chart on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Clinics - Year-over-year growth 2024-2029 (%)
Exhibits 62: Market opportunity by End-user ($ billion)
Exhibits 63: Data Table on Market opportunity by End-user ($ billion)
Exhibits 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 65: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 66: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 67: Chart on Geographic comparison
Exhibits 68: Data Table on Geographic comparison
Exhibits 69: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 70: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 71: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 74: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 75: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 77: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 78: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 79: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 80: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 85: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 86: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 87: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 88: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 89: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 90: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 91: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 94: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 95: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 98: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 99: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 102: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 103: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 106: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 107: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 110: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 111: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 114: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 115: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 118: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Russia - Market size and forecast 2024-2029 ($ billion)
Exhibits 122: Data Table on Russia - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Chart on Russia - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Russia - Year-over-year growth 2024-2029 (%)
Exhibits 125: Market opportunity By Geographical Landscape ($ billion)
Exhibits 126: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 127: Impact of drivers and challenges in 2024 and 2029
Exhibits 128: Overview on criticality of inputs and factors of differentiation
Exhibits 129: Overview on factors of disruption
Exhibits 130: Impact of key risks on business
Exhibits 131: Companies covered
Exhibits 132: Company ranking index
Exhibits 133: Matrix on companies position and classification
Exhibits 134: Astellas Pharma Inc. - Overview
Exhibits 135: Astellas Pharma Inc. - Product/Service
Exhibits 136: Astellas Pharma Inc. - Key offerings
Exhibits 137: SWOT
Exhibits 138: AstraZeneca Plc - Overview
Exhibits 139: AstraZeneca Plc - Product/Service
Exhibits 140: AstraZeneca Plc - Key news
Exhibits 141: AstraZeneca Plc - Key offerings
Exhibits 142: SWOT
Exhibits 143: Bavarian Nordic AS - Overview
Exhibits 144: Bavarian Nordic AS - Product/Service
Exhibits 145: Bavarian Nordic AS - Key offerings
Exhibits 146: SWOT
Exhibits 147: Bharat Biotech Ltd. - Overview
Exhibits 148: Bharat Biotech Ltd. - Product/Service
Exhibits 149: Bharat Biotech Ltd. - Key offerings
Exhibits 150: SWOT
Exhibits 151: BrightPath Biotherapeutics Co., Ltd. - Overview
Exhibits 152: BrightPath Biotherapeutics Co., Ltd. - Product/Service
Exhibits 153: BrightPath Biotherapeutics Co., Ltd. - Key offerings
Exhibits 154: SWOT
Exhibits 155: CSL Ltd. - Overview
Exhibits 156: CSL Ltd. - Business segments
Exhibits 157: CSL Ltd. - Key news
Exhibits 158: CSL Ltd. - Key offerings
Exhibits 159: CSL Ltd. - Segment focus
Exhibits 160: SWOT
Exhibits 161: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 162: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 163: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 164: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 165: SWOT
Exhibits 166: Emergent BioSolutions Inc. - Overview
Exhibits 167: Emergent BioSolutions Inc. - Product/Service
Exhibits 168: Emergent BioSolutions Inc. - Key offerings
Exhibits 169: SWOT
Exhibits 170: GSK Plc - Overview
Exhibits 171: GSK Plc - Business segments
Exhibits 172: GSK Plc - Key news
Exhibits 173: GSK Plc - Key offerings
Exhibits 174: GSK Plc - Segment focus
Exhibits 175: SWOT
Exhibits 176: Gradalis Inc. - Overview
Exhibits 177: Gradalis Inc. - Product/Service
Exhibits 178: Gradalis Inc. - Key offerings
Exhibits 179: SWOT
Exhibits 180: Johnson and Johnson Inc. - Overview
Exhibits 181: Johnson and Johnson Inc. - Business segments
Exhibits 182: Johnson and Johnson Inc. - Key news
Exhibits 183: Johnson and Johnson Inc. - Key offerings
Exhibits 184: Johnson and Johnson Inc. - Segment focus
Exhibits 185: SWOT
Exhibits 186: Merck KGaA - Overview
Exhibits 187: Merck KGaA - Business segments
Exhibits 188: Merck KGaA - Key news
Exhibits 189: Merck KGaA - Key offerings
Exhibits 190: Merck KGaA - Segment focus
Exhibits 191: SWOT
Exhibits 192: Novavax Inc. - Overview
Exhibits 193: Novavax Inc. - Product/Service
Exhibits 194: Novavax Inc. - Key offerings
Exhibits 195: SWOT
Exhibits 196: Pfizer Inc. - Overview
Exhibits 197: Pfizer Inc. - Product/Service
Exhibits 198: Pfizer Inc. - Key news
Exhibits 199: Pfizer Inc. - Key offerings
Exhibits 200: SWOT
Exhibits 201: Sanofi SA - Overview
Exhibits 202: Sanofi SA - Business segments
Exhibits 203: Sanofi SA - Key news
Exhibits 204: Sanofi SA - Key offerings
Exhibits 205: Sanofi SA - Segment focus
Exhibits 206: SWOT
Exhibits 207: Inclusions checklist
Exhibits 208: Exclusions checklist
Exhibits 209: Currency conversion rates for US$
Exhibits 210: Research methodology
Exhibits 211: Information sources
Exhibits 212: Data validation
Exhibits 213: Validation techniques employed for market sizing
Exhibits 214: Data synthesis
Exhibits 215: 360 degree market analysis
Exhibits 216: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global vaccines market: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co., Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GSK Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is development of nanoparticle vaccines."

According to the report, one of the major drivers for this market is the increased funding for vaccine development and new vaccine launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • BrightPath Biotherapeutics Co. Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GSK Plc
  • Gradalis Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Inc.
  • Merck KGaA
  • Mitsubishi Chemical Group Corp.
  • Novavax Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva SE